This study found that the dermal papilla of the hairfollicle regulates stem cell quiescence and regeneration by modulating Shh and Wnt signaling pathways, highlighting the importance of signaling cross talk in regeneration.
This study suggests that hairfollicle-derived mesenchymal stem cell transplantation may effectively treat acute pancreatitis by reducing inflammation and promoting pancreatic regeneration in a rat model.
12 citations
,
April 2022 in “Frontiers in Cell and Developmental Biology”
This study found that stabilizing β-catenin in a specific mouse model led to temporarily increased hair density but ultimately accelerated hairfollicle aging and hair thinning.
April 2019 in “The journal of investigative dermatology/Journal of investigative dermatology”
This study in mice suggests that defects in hairfollicles with mesenchymal TSC2 disruption may result from an impaired TGFβ1 response, indicating a potential novel treatment approach for tuberous sclerosis complex.
PP405 may encourage earlier hair growth and slightly increase visible hair count but does not reverse hairfollicle miniaturization in male pattern baldness. It does not address damage to the dermal papilla or broken Wnt signaling.
AMP-303 and AMP-601 are new hair loss treatments targeting dermal papilla cells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.
Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.
Hair loss treatments like finasteride, minoxidil, and hair transplants have side effects and limitations. There is hope for future advancements in stem cell therapy and hairfollicle regeneration, though skepticism about their effectiveness and timeline persists.
Japanese scientists discovered ABM cells, enabling successful human hairfollicle cloning, potentially curing hair loss. The treatment may be available in Japan by 2028, but it will be expensive and require travel.